Page last updated: 2024-09-02

ecteinascidin 743 and Peritoneal Carcinomatosis

ecteinascidin 743 has been researched along with Peritoneal Carcinomatosis in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Esser, M; Fritz, J; Horger, M; Kloth, C; Kopp, HG; Reinert, CP; Thaiss, WM1
Adam, J; Ahlenc-Gelas, M; Cavalcanti, A; Domitrescu, G; Dumont, S; El Amarti, L; Honore, C; Kiavue, N; Klausner, G; Le Cesne, A; Mir, O; Sourrouille, I; Terrier, P; Verret, B1
Adenis, A; Hollebecque, A; Lebedinsky, C; Penel, N; Taieb, S1
Bonebrake, AJ; De Geest, K; Edwards, R; Hanjani, P; Monk, BJ; Rotmensch, J; Sill, MW; Walker, JL1
Markman, M1

Trials

2 trial(s) available for ecteinascidin 743 and Peritoneal Carcinomatosis

ArticleYear
Docetaxel plus trabectedin appears active in recurrent or persistent ovarian and primary peritoneal cancer after up to three prior regimens: a phase II study of the Gynecologic Oncology Group.
    Gynecologic oncology, 2011, Volume: 120, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Dioxoles; Docetaxel; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Peritoneal Neoplasms; Taxoids; Tetrahydroisoquinolines; Trabectedin

2011
Docetaxel plus trabectedin appears active in recurrent or persistent ovarian and primary peritoneal cancer after up to three prior regimes: a phase II study of the Gynecologic Oncology Group.
    Gynecologic oncology, 2011, Volume: 122, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Dioxoles; Docetaxel; Female; Humans; Neoplasm Recurrence, Local; Ovarian Neoplasms; Peritoneal Neoplasms; Taxoids; Tetrahydroisoquinolines; Trabectedin

2011

Other Studies

3 other study(ies) available for ecteinascidin 743 and Peritoneal Carcinomatosis

ArticleYear
CT-response patterns and the role of CT-textural features in inoperable abdominal/retroperitoneal soft tissue sarcomas treated with trabectedin.
    European journal of radiology, 2018, Volume: 107

    Topics: Abdominal Neoplasms; Adult; Aged; Antineoplastic Agents, Alkylating; Female; Humans; Male; Middle Aged; Peritoneal Neoplasms; Retrospective Studies; Sarcoma; Sensitivity and Specificity; Soft Tissue Neoplasms; Tomography, X-Ray Computed; Trabectedin

2018
Trabectedin in advanced desmoplastic round cell tumors: a retrospective single-center series.
    Anti-cancer drugs, 2017, Volume: 28, Issue:1

    Topics: Adult; Antineoplastic Agents, Alkylating; Desmoplastic Small Round Cell Tumor; Dioxoles; Female; Humans; Infusions, Intravenous; Liver Neoplasms; Male; Middle Aged; Peritoneal Neoplasms; Pleural Neoplasms; Retrospective Studies; Tetrahydroisoquinolines; Trabectedin; Young Adult

2017
Inadequacy of size-based response criteria to assess the efficacy of trabectedin among metastatic sarcoma patients.
    Investigational new drugs, 2010, Volume: 28, Issue:4

    Topics: Antineoplastic Agents, Alkylating; Clinical Trials, Phase II as Topic; Dioxoles; Humans; Leiomyosarcoma; Male; Middle Aged; Neoplasm Metastasis; Peritoneal Neoplasms; Tetrahydroisoquinolines; Trabectedin; Treatment Outcome

2010